Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9

Microbes and Infection

Volumn 11, Issue 4, 2009, Pages 515-523

  Xie, Qing ^a   Shen, Huai Cheng ^a   Jia, Ni Na ^a   Wang, Hui ^a   Lin, Lan Yi ^a   An, Bao Yan ^a   Gui, Hong Lian ^a   Guo, Si Min ^a   Cai, Wei ^a   Yu, Hong ^a   Guo, Qing ^a   Bao, Shisan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Institute for Biomedical Research   (Australia)

Author keywords

HBV; IFN ; pDCs; TLR9

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CYTIDINE PHOSPHATE; GUANOSINE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; TOLL LIKE RECEPTOR 9;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; CELL COUNT; CELL FUNCTION; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; TOLL-LIKE RECEPTOR 9; VIRAL LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 64749099759     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.02.008     Document Type: Article

References (28)

1. Webster G.J., Reignat S., Maini M.K., Whalley S.A., Ogg G.S., King A., Brown D., Amlot P.L., Williams R., Vergani D., Dusheiko G.M., and Bertoletti A. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32 (2000) 1117-1124
2. Marinos G., Torre F., Chokshi S., Hussain M., Clarke B.E., Rowlands D.J., Eddleston A.L., Naoumov N.V., and Williams R. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 22 (1995) 1040-1049
3. Cella M., Facchetti F., Lanzavecchia A., and Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1 (2000) 305-310
4. + dendritic cells. J. Immunol. 166 (2001) 5000-5007
5. Kadowaki N., Antonenko S., Lau J.Y., and Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192 (2000) 219-226
6. Liu C.J., Lai M.Y., Chao Y.C., Liao L.Y., Yang S.S., Hsiao T.J., Hsieh T.Y., Lin C.L., Hu J.T., Chen C.L., Chen P.J., Kao J.H., and Chen D.S. Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study. Hepatology 43 (2006) 742-749
7. Barchet W., Cella M., and Colonna M. Plasmacytoid dendritic cells - virus experts of innate immunity. Semin. Immunol. 17 (2005) 253-261
8. Szabo G., Dolganiuc A., and Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44 (2006) 287-298
9. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198 (2003) 513-520
10. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., and Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004) 107-119
11. Huang X.X., McCaughan G.W., Shackel N.A., and Gorrell M.D. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Liver Int. 27 (2007) 960-968
12. Bochud P.Y., Hersberger M., Taffe P., Bochud M., Stein C.M., Rodrigues S.D., Calandra T., Francioli P., Telenti A., Speck R.F., Aderem A., and H.I.V.C.S. the Swiss. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21 (2007) 441-446
13. Cooper C.L., Davis H.L., Morris M.L., Efler S.M., Adhami M.A., Krieg A.M., Cameron D.W., and Heathcote J. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J. Clin. Immunol. 24 (2004) 693-701
14. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
15. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., Mounzer K., Kostman J., Trinchieri G., and Montaner L.J. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 168 (2002) 4796-4801
16. Ulsenheimer A., Gerlach J.T., Jung M.C., Gruener N., Wachtler M., Backmund M., Santantonio T., Schraut W., Heeg M.H., Schirren C.A., Zachoval R., Pape G.R., and Diepolder H.M. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41 (2005) 643-651
17. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., Kwekkeboom J., and Janssen H.L. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40 (2004) 738-746
18. Xu N., Yao H.P., Sun Z., and Chen Z. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol. Sin. 29 (2008) 239-244
19. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002) 4531-4537
20. Takeshita F., Suzuki K., Sasaki S., Ishii N., Klinman D.M., and Ishii K.J. Transcriptional regulation of the human TLR9 gene. J. Immunol. 173 (2004) 2552-2561
21. Duan X.Z., Wang M., Li H.W., Zhuang H., Xu D., and Wang F.S. Decreased frequency and function of circulating plasmacytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 24 (2004) 637-646
22. Wang K., Fan X., Fan Y., Wang B., Han L., and Hou Y. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection. J. Viral Hepat. 14 (2007) 276-282
23. Legge K.L., and Braciale T.J. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18 (2003) 265-277
24. Colonna M., Krug A., and Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14 (2002) 373-379
25. Beckebaum S., Cicinnati V.R., Dworacki G., Muller-Berghaus J., Stolz D., Harnaha J., Whiteside T.L., Thomson A.W., Lu L., Fung J.J., and Bonham C.A. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin. Immunol. 104 (2002) 138-150
26. Untergasser A., Zedler U., Langenkamp A., Hosel M., Quasdorff M., Esser K., Dienes H.P., Tappertzhofen B., Kolanus W., and Protzer U. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 43 (2006) 539-547
27. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., Oki C., Itose I., Hiramatsu N., Takehara T., Kasahara A., and Hayashi N. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190 (2004) 1919-1926
28. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., and Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003) 225-234